381: The future of American science and a dispatch from ASH
How did Terns Pharmaceuticals and its “hodgepodge” pipeline grab attention at the American Society of Hematology conference? Is Eli Lilly’s new drug making people lose too much weight? And what, exact...
11 Des 202533min
380: A new top drug regulator and the future of psychedelics
On this week’s episode of "The Readout Loud": a look at an emerging class of psychedelic drugs that may treat depression, anxiety, and other psychiatric conditions without the hallucinogenic “trip.” P...
4 Des 202532min
379: How Mark Cuban plans to ‘f— up’ health care
How much time does Mark Cuban spend thinking about health care? Why does he think TrumpRx, a direct drug purchasing platform that the Trump administration aims to launch, is “the most incredible progr...
20 Nov 202537min
378: Merck's heart disease win and the FDA's new drug regulator
What does Rick Pazdur's new role mean for the Food and Drug Administration? Has Merck solved the PCSK9 access issue? And how much credit can the president take for lowering GLP-1 drug prices? Dean Li...
13 Nov 202536min
377: Melodrama at the FDA and the Pfizer-Novo bidding war
On a jam-packed show, your co-hosts, minus the vacationing Allison DeAngelis, chat with STAT’s D.C. correspondent Lizzy Lawrence about a slow-boiling feud between Vinay Prasad, the head of the FDA’s b...
6 Nov 202531min
376: BridgeBio’s great week and Moderna’s unraveling
Has BridgeBio’s business model worked? How are executives at Moderna dealing with the company’s slump? And who will the hosts dress up as for Halloween? We discuss all that on this week’s episode of ...
30 Okt 202538min
375: Startups push the FDA and biotech booms in North Carolina
Can Trump take credit for North Carolina's booming biopharma industry? Which drugs could get a shortcut to the market? And who wore a tuxedo to the STAT Summit? We discuss all that and more in the la...
23 Okt 202529min
374: Veteran biotech executive Clive Meanwell on drug pricing and the obesity market
On this week’s episode of “The Readout LOUD”: an interview with veteran biotech executive and company founder Clive Meanwell. Pfizer recently acquired one of Meanwell’s companies, the obesity drug dev...
16 Okt 202534min
